tiprankstipranks
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Income Statement

Compare
1 Followers

Oryzon Genomics SA Income Statement

Last quarter (Q2 2024), Oryzon Genomics SA's total revenue was €4.11M, an increase of Infinity% from the same quarter last year. In Q2, Oryzon Genomics SA's net income was €107.17K. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 14.19M€ 0.00€ 0.00€ 0.00€ 0.00
Gross Profit
€ 13.95M€ 15.23M€ 9.87M€ 8.99M€ 0.00
Operating Expenses
€ 18.50M€ 20.72M€ 16.88M€ 13.28M€ 10.55M
Depreciation and Amortization
€ 152.88K€ 166.66K€ 144.33K€ 145.05K€ 0.00
EBITDA
€ -4.43M€ -5.35M€ -6.88M€ -4.16M€ -3.70M
Operating Income
€ -4.55M€ -5.49M€ -7.01M€ -4.29M€ -10.55M
Other Income/Expenses
€ -1.55M€ -1.07M€ -169.31K€ -484.51K€ 0.00
Pretax Income
€ -6.10M€ -6.56M€ -7.18M€ -4.78M€ 0.00
Net Income
€ -3.35M€ -4.23M€ -4.69M€ -3.40M€ 0.00
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -0.06€ -0.08€ -0.09€ -0.06€ 0.00
Diluted EPS
€ -0.06€ -0.08€ -0.09€ -0.06€ 0.00
Weighted Average Shares Outstanding
60.88M 56.04M 52.76M 52.76M 52.76M
Weighted Average Shares Outstanding (Diluted)
60.88M 56.04M 52.76M 52.76M 52.76M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis